78 related articles for article (PubMed ID: 7581161)
1. Availability and appropriateness of allo-BMT for CML: the Italian experience.
Marmont A; Gualandi F
Bone Marrow Transplant; 1995 Aug; 16(2):325-6. PubMed ID: 7581161
[No Abstract] [Full Text] [Related]
2. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
3. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
4. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
[TBL] [Abstract][Full Text] [Related]
5. [Allogeneic bone marrow transplantation for chronic myeloid leukemia: 118 cases analysis].
Liu D; Guo N; Zhang Y
Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):424-6. PubMed ID: 11721424
[TBL] [Abstract][Full Text] [Related]
6. [Clinical factors that affect the detection of BCR-ABL transcripts after allogenic bone marrow transplantation for chronic myeloid leukemia].
Román J; García MJ; Martín C; Sánchez J; Serrano J; Falcón M; Castillejo JA; Navarro JA; Flores R; Torres A
Med Clin (Barc); 1998 Oct; 111(11):405-9. PubMed ID: 9834912
[TBL] [Abstract][Full Text] [Related]
7. Deficit of T-cell recovery after allogeneic bone marrow transplantation in chronic myeloid leukemia patients.
Diamond HR; Souza MH; Bouzas LF; Tabak DG; Campos MM; Câmara FP; Rumjanek VM
Anticancer Res; 1995; 15(4):1553-60. PubMed ID: 7654044
[TBL] [Abstract][Full Text] [Related]
8. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
[TBL] [Abstract][Full Text] [Related]
9. [Molecular analysis of bcr-abl mRNA during long-term follow-up of cases of chronic myelogenous leukemia].
Nakamura K; Okamoto N; Mizutani S
Rinsho Ketsueki; 1994 Sep; 35(9):853-61. PubMed ID: 7967054
[TBL] [Abstract][Full Text] [Related]
10. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
11. European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Devergie A; Apperley JF; Labopin M; Madrigal A; Jacobsen N; Carreras E; Prentice HG; Jouet JP; Kolb HJ; Herstenstein B; Bacigalupo A; Evensen SA; Ljungman P; de Witte T; Reiffers J; Nagler A; Clark RE; Goldman JM; Gratwohl A
Bone Marrow Transplant; 1997 Jul; 20(1):11-9. PubMed ID: 9232250
[TBL] [Abstract][Full Text] [Related]
12. [Acute myeloid leukemia].
Bol P
Ned Tijdschr Tandheelkd; 2002 Nov; 109(11):463-4. PubMed ID: 12494710
[No Abstract] [Full Text] [Related]
13. [Bone marrow transplantation in chronic myeloid leukemia].
Milone JH; Bordone J; Etchegoyen O; Napal J; Prates MV; Morales VH
Medicina (B Aires); 1999; 59(1):1-10. PubMed ID: 10349111
[TBL] [Abstract][Full Text] [Related]
14. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
[TBL] [Abstract][Full Text] [Related]
15. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
[TBL] [Abstract][Full Text] [Related]
16. Timing of allogeneic BMT for CML patients in India: does it affect response?
Sazawal S; Hasan SK; Kumar B; Kumar R; Kumar L; Saxena R
Am J Hematol; 2007 Apr; 82(4):329. PubMed ID: 16947319
[No Abstract] [Full Text] [Related]
17. [Results of treating chronic myelogenous leukemia in children].
Derulska D; Rokicka-Milewska R; Armata J; Bogusławska-Jaworska J; Depowska T; Krauze A; Kowalczyk J; Radziewicz-Magott B; Nowak T; Ochocka M
Acta Haematol Pol; 1993; 24(1):43-8. PubMed ID: 7683837
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
[No Abstract] [Full Text] [Related]
19. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
[No Abstract] [Full Text] [Related]
20. Autografting in chronic myelogenous leukemia followed by immunotherapy.
Rowe J; Ryan D; Dipersio J; Gaspari A; Nilsson B; Larsson L; Liesveld J; Kouides P; Simonsson B
Stem Cells; 1993 Oct; 11 Suppl 3():34-42. PubMed ID: 8298476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
